- Email: [email protected]
Corrigendum to “MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68” [Vaccine 29 (2011) 3935–3944]
Vaccine 30 (2012) 3145
Contents lists available at SciVerse ScienceDirect
Vaccine journal homepage: www.elsevier.com/locate/vaccine
Corrigendum
Corrigendum to “MHV-68 producing mIFN␣1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68” [Vaccine 29 (2011) 3935–3944] Eleonora Aricò a,∗ , Domenica M. Monque a , Giuseppina D’Agostino a , Federica Moschella a , Massimo Venditti a , Ulrich Kalinke b , Deborah J. Allen c , James P. Stewart d , Anthony A. Nash c , Filippo Belardelli a , Maria Ferrantini a a
Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625 Hannover, Germany c Centre for Infectious Diseases, The Roslin Institute, University of Edinburgh, Edinburgh, UK d Department of Infection Biology, University of Liverpool, Liverpool, UK b
The authors would like to rectify an error that occurred in their article. James P. Stewart was mistakenly omitted from the published list of authors. His details have now been added. The authors apologize for any inconvenience caused.
DOI of original article: 10.1016/j.vaccine.2011.03.092. ∗ Corresponding author. Tel.: +39 06 4990 3004; fax: +39 06 4990 2140. E-mail address: [email protected] (E. Aricò). 0264-410X/$ – see front matter © 2012 Elsevier Ltd. All rights reserved. doi:10.1016/j.vaccine.2012.02.045
Contents lists available at SciVerse ScienceDirect
Vaccine journal homepage: www.elsevier.com/locate/vaccine
Corrigendum
Corrigendum to “MHV-68 producing mIFN␣1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68” [Vaccine 29 (2011) 3935–3944] Eleonora Aricò a,∗ , Domenica M. Monque a , Giuseppina D’Agostino a , Federica Moschella a , Massimo Venditti a , Ulrich Kalinke b , Deborah J. Allen c , James P. Stewart d , Anthony A. Nash c , Filippo Belardelli a , Maria Ferrantini a a
Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625 Hannover, Germany c Centre for Infectious Diseases, The Roslin Institute, University of Edinburgh, Edinburgh, UK d Department of Infection Biology, University of Liverpool, Liverpool, UK b
The authors would like to rectify an error that occurred in their article. James P. Stewart was mistakenly omitted from the published list of authors. His details have now been added. The authors apologize for any inconvenience caused.
DOI of original article: 10.1016/j.vaccine.2011.03.092. ∗ Corresponding author. Tel.: +39 06 4990 3004; fax: +39 06 4990 2140. E-mail address: [email protected] (E. Aricò). 0264-410X/$ – see front matter © 2012 Elsevier Ltd. All rights reserved. doi:10.1016/j.vaccine.2012.02.045